These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 38538285)

  • 1. The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium.
    Mitaishvili E; Feinsod H; David Z; Shpigel J; Fernandez C; Sauane M; de la Parra C
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):99. PubMed ID: 38538285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
    Jia D; Lu M; Jung KH; Park JH; Yu L; Onuchic JN; Kaipparettu BA; Levine H
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3909-3918. PubMed ID: 30733294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
    Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
    Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
    Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
    Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming in triple-negative breast cancer.
    Wang Z; Jiang Q; Dong C
    Cancer Biol Med; 2020 Feb; 17(1):44-59. PubMed ID: 32296576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying the Metabolism of Epithelial-Mesenchymal Plasticity Using the Seahorse XFe96 Extracellular Flux Analyzer.
    Bhatia S; Thompson EW; Gunter JH
    Methods Mol Biol; 2021; 2179():327-340. PubMed ID: 32939731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment.
    Baek ML; Lee J; Pendleton KE; Berner MJ; Goff EB; Tan L; Martinez SA; Mahmud I; Wang T; Meyer MD; Lim B; Barrish JP; Porter W; Lorenzi PL; Echeverria GV
    Oncogene; 2023 Mar; 42(14):1117-1131. PubMed ID: 36813854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer.
    Tailor D; Going CC; Resendez A; Kumar V; Nambiar DK; Li Y; Dheeraj A; LaGory EL; Ghoochani A; Birk AM; Stoyanova T; Ye J; Giaccia AJ; Le QT; Singh RP; Sledge GW; Pitteri SJ; Malhotra SV
    Br J Cancer; 2021 Feb; 124(3):604-615. PubMed ID: 33139797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
    Blomme A; Costanza B; de Tullio P; Thiry M; Van Simaeys G; Boutry S; Doumont G; Di Valentin E; Hirano T; Yokobori T; Gofflot S; Peulen O; Bellahcène A; Sherer F; Le Goff C; Cavalier E; Mouithys-Mickalad A; Jouret F; Cusumano PG; Lifrange E; Muller RN; Goldman S; Delvenne P; De Pauw E; Nishiyama M; Castronovo V; Turtoi A
    Oncogene; 2017 Apr; 36(15):2116-2130. PubMed ID: 27775075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1α and p53 activity in triple-negative breast cancer.
    Du Y; Wei N; Ma R; Jiang S; Song D
    Cell Death Dis; 2020 Sep; 11(9):731. PubMed ID: 32908121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FR58P1a; a new uncoupler of OXPHOS that inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway.
    Urra FA; Muñoz F; Córdova-Delgado M; Ramírez MP; Peña-Ahumada B; Rios M; Cruz P; Ahumada-Castro U; Bustos G; Silva-Pavez E; Pulgar R; Morales D; Varela D; Millas-Vargas JP; Retamal E; Ramírez-Rodríguez O; Pessoa-Mahana H; Pavani M; Ferreira J; Cárdenas C; Araya-Maturana R
    Sci Rep; 2018 Sep; 8(1):13190. PubMed ID: 30181620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
    Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN
    FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
    Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
    Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect.
    Abukwaik R; Vera-Siguenza E; Tennant D; Spill F
    Bull Math Biol; 2024 Aug; 86(10):124. PubMed ID: 39207627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.
    Jia D; Park JH; Jung KH; Levine H; Kaipparettu BA
    Cells; 2018 Mar; 7(3):. PubMed ID: 29534029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of metabolism-related proteins in triple-negative breast cancer.
    Kim MJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(1):301-12. PubMed ID: 24427351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer.
    Wang Y; Harada-Shoji N; Kitamura N; Yamazaki Y; Ebata A; Amari M; Watanabe M; Miyashita M; Tada H; Abe T; Suzuki T; Gonda K; Ishida T
    Cancer Med; 2024 Jan; 13(2):e6987. PubMed ID: 38334464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells.
    Rossi T; Zamponi R; Chirico M; Pisanu ME; Iorio E; Torricelli F; Gugnoni M; Ciarrocchi A; Pistoni M
    J Exp Clin Cancer Res; 2023 Jan; 42(1):7. PubMed ID: 36604676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.